Neurological Manifestations of progressive hemifacial atrophy-case report

Authors

  • Saima Manzoor Sir Gangaram Hospital Lahore
  • Javeria Zulfiqar Department of Dermatology, Sir Gangaram Hospital Lahore
  • Nadia Ali Azfar Department of Dermatology, Sir Gangaram Hospital Lahore
  • Muhammad Nadeem Department of Dermatology, Sir Gangaram Hospital Lahore

DOI:

https://doi.org/10.66344/jpad.v31i4.1776

Abstract

Progressive hemifacial atrophy is a rare, unilateral, atrophic craniofacial form of morphea involving the dermis, subcutaneous tissue, fat, muscle, and even bone. We report a case of a child having progressive hemifacial atrophy, presented with rapidly progressive neurological symptoms and associated radiological manifestations. In this case of hemifacial atrophy, the sensitivity of MRI in detecting intracranial lesions is demonstrated. Recommendations for imaging these patients are proposed.

References

1. El-Kehdy J, Abbas O, Rubeiz N. A review of Parry-Romberg syndrome. J Am Acad Dermatol. 2012 Oct;67(4):769-84. doi: 10.1016/j.jaad.2012.01.019. Epub 2012 Mar 7. PMID: 22405645.Wolf SM, Verity MA Neurological complications of progressive facial hemiatrophy. J Neurol Neurosurg Psychiatry.1974;37:997-1004.

2. R C Cory, D A Clayman, W J Faillace, S W McKee and C H Gama. Clinical and radiologic findings in progressive facial hemiatrophy (Parry-Romberg syndrome). AJNR Am J Neuroradiol.1997;18(4):751-7.

3. Wolf SM, Verity MA Neurological complications of progressive facial hemiatrophy. J Neurol Neurosurg Psychiatry.1974;37:997-1004.

4. Nicholas Mazzeo, Jon G. Fisher, Michael H. Mayer, Gregory P. Mathieu, Progressive hemifacial atrophy (Parry-Romberg syndrome) Case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.1995; 79(1):30-5.

5. Orozco-Covarrubias L, Guzman-Meza A, Ridaura-Sanz C, Carrasco Daza D, Sosa-de-Martinez C, Ruiz-Maldonado R. Scleroderma ‘en coup de sabre’ and progressive facial hemiatrophy. Is it possible to differentiate them? J Eur Acad Dermatol Venereol.2002;16(4):361–6.

6. Orteu CH. Morphea and Allied Scarring and Sclerosing Inflammatory Dermatoses. In: Griffiths CE, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook's Textbook of Dermatology. 9th ed. Oxford: Wiley Blackwell; 2016. p. 1567.

7. Vix, Justine MD; Mathis, Stéphane MD, PhD; Lacoste, Mathieu MD; Guillevin, Rémy MD, PhD; Neau, Jean-Philippe MD Neurological Manifestations in Parry–Romberg Syndrome, Medicine: July 2015 - Volume 94 - Issue 28 - p e1147

8. R C Cory, D A Clayman, W J Faillace, S W McKee and C H Gama American Journal of Neuroradiology April 1997, 18 (4) 751-757;

9. Zulian F, Vallongo C, Patrizi A, Belloni-Fortina A, Cutrone M, Alessio M, et al. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea). J Am Acad Dermatol.2012;67(6):1151–6. doi:10.1016/j.jaad.2012.03.036.

10. Vix J, Mathis S, Lacoste M, Guillevin R, Neau JP. Neurological Manifestations in Parry-Romberg Syndrome: 2 Case Reports. Medicine. 2015;94(28):e1147.

doi:10.1097/MD.0000000000001147.

Downloads

Published

29.03.2022

How to Cite

1.
Neurological Manifestations of progressive hemifacial atrophy-case report. J Pak Assoc Dermatol [Internet]. 2022 Mar. 29 [cited 2026 Aug. 1];31(4):731-4. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1776